ProCE Banner Activity

Proviral DNA Resistance Testing: Uses and Limitations When Switching ART

Clinical Thought

Here are my thoughts on the role of proviral DNA genotypic resistance testing for treatment-experienced people with HIV when switching ART in the setting of viral suppression, including when switching to long-acting ART.

Released: February 06, 2023

Expiration: February 05, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare